Search results for "Protein"

showing 10 items of 21431 documents

Endothelial nitric oxide synthase in vascular disease: from marvel to menace.

2006

Nitric oxide (NO·) is an important protective molecule in the vasculature, and endothelial NO· synthase (eNOS) is responsible for most of the vascular NO· produced. A functional eNOS oxidizes its substrate l -arginine to l -citrulline and NO·. This normal function of eNOS requires dimerization of the enzyme, the presence of the substrate l -arginine, and the essential cofactor (6 R )-5,6,7,8-tetrahydro- l -biopterin (BH 4 ), one of the most potent naturally occurring reducing agents. Cardiovascular risk factors such as hypertension, hypercholesterolemia, diabetes mellitus, or chronic smoking stimulate the production of reactive oxygen species in the vascular wall. Nicotinamide adenine dinu…

medicine.medical_specialtyEndotheliumNitric Oxide Synthase Type IIINitric OxideNitric oxidechemistry.chemical_compoundEnosPhysiology (medical)Internal medicinemedicineAnimalsHumansVascular Diseaseschemistry.chemical_classificationReactive oxygen speciesbiologySuperoxidebusiness.industrybiology.organism_classificationNitric oxide synthaseOxidative Stressmedicine.anatomical_structureEndocrinologychemistrybiology.proteinEndothelium VascularCardiology and Cardiovascular MedicinebusinessReactive Oxygen SpeciesNicotinamide adenine dinucleotide phosphatePeroxynitriteCirculation
researchProduct

Isoflavones and cardiovascular disease

2010

The specific profile of estrogens on cardiovascular risk, with limiting action on atherogenesis but a less clear protection on cardiovascular episodes, might be improved by other agonists of the estrogen receptor, such as isoflavones. By using a systematic search based on the electronic Medline database plus a hand-search of reference lists of selected review papers, we reviewed the rapidly growing body of experimental and clinical data that, on average, follow a pattern of benefit rather similar to estrogens. Experimental models have used endothelial and vascular smooth muscle cells, isolated arteries, and live animals, including monkeys. The clinical evidence arises from studies on the li…

medicine.medical_specialtyEndotheliumPhysiologyProstacyclinMuscle Smooth VascularGeneral Biochemistry Genetics and Molecular Biologychemistry.chemical_compoundInsulin resistanceLipid oxidationInternal medicineAnimalsHumansMedicineEvidence-Based Medicinemedicine.diagnostic_testbusiness.industrySoy FoodsObstetrics and GynecologyIsoflavonesLipid Metabolismmedicine.diseaseIsoflavonesPostmenopauseMenopauseEndocrinologymedicine.anatomical_structurechemistryCardiovascular DiseasesHemostasisSoybean ProteinsWomen's HealthFemaleEndothelium VascularbusinessLipid profilemedicine.drugMaturitas
researchProduct

Expression of different isoforms of nitric oxide synthase in experimentally denervated and reinnervated skeletal muscle.

1997

Denervated muscle fibers express enhanced levels of stress and apoptosis-associated proteins and undergo apoptosis. In experimentally denervated and reinnervated rat facial muscle, we now evaluate changes in the expression patterns of different isoforms of nitric oxide synthase (NOS)-generating nitric oxide (NO), which mediates oxidative stress and apoptosis. Physiological expression of NOS corresponds to a constant sarcolemmal staining pattern for neuronal NOS (nNOS) and a patchy sarcolemmal and weak sarcoplasmic labeling for the endothelial NOS-isoform, with no expression for inducible NOS (iNOS). Denervated muscle displayed distinct downregulation of nNOS with preserved expression of dys…

medicine.medical_specialtyEndotheliumSarcoplasmFacial MusclesPathology and Forensic MedicineNitric oxideCellular and Molecular Neurosciencechemistry.chemical_compoundDownregulation and upregulationReference ValuesInternal medicinemedicineAnimalsEndotheliumRats WistarDenervationbiologySkeletal muscleGeneral MedicineMuscle DenervationNerve RegenerationRatsNitric oxide synthaseIsoenzymesmedicine.anatomical_structureEndocrinologyNeurologychemistryEnzyme Inductionbiology.proteinFemaleNeurology (clinical)Nitric Oxide SynthaseDystrophinJournal of neuropathology and experimental neurology
researchProduct

Sirolimus-Induced Vascular Dysfunction

2008

Objectives This study sought to analyze mechanisms that mediate vascular dysfunction induced by sirolimus. Background Despite excellent antirestenotic capacity, sirolimus-eluting stents have been found to trigger coronary endothelial dysfunction and impaired re-endothelialization. Methods To mimic the continuous sirolimus exposure of a stented vessel, Wistar rats underwent drug infusion with an osmotic pump for 7 days. Results Sirolimus treatment caused a marked degree of endothelial dysfunction as well as a desensitization of the vasculature to the endothelium-independent vasodilator nitroglycerin. Also, sirolimus stimulated intense transmural superoxide formation as detected by dihydroeth…

medicine.medical_specialtyEndotheliumVasodilationNitric oxidechemistry.chemical_compoundInternal medicinemedicinecardiovascular diseasesEndothelial dysfunctionNADPH oxidaseNicotinamidebiologybusiness.industrySuperoxideequipment and suppliesmedicine.diseasesurgical procedures operativemedicine.anatomical_structureEndocrinologychemistrySirolimuscardiovascular systembiology.proteinCardiology and Cardiovascular Medicinebusinessmedicine.drugJournal of the American College of Cardiology
researchProduct

Adhesion molecules, endothelial products, and microalbuminuria in essential hypertension

2001

medicine.medical_specialtyEndotheliumbiologybusiness.industryCell adhesion moleculeIntercellular Adhesion Molecule-1Essential hypertensionmedicine.diseaseEndothelin 1medicine.anatomical_structureEndocrinologyInternal medicineE-selectinInternal Medicinemedicinebiology.proteinMicroalbuminuriaEndothelial dysfunctionbusinessAmerican Journal of Hypertension
researchProduct

Endothelial activation and insulin resistance: Comparison between essential hypertensives and hypertensive patients with Metabolic Syndrome

2005

medicine.medical_specialtyEndotheliumbiologybusiness.industryInsulinmedicine.medical_treatmentmedicine.diseaseEndothelial activationInsulin resistancemedicine.anatomical_structureEndocrinologyBlood pressureVon Willebrand factorInternal medicineInternal Medicinemedicinebiology.proteinEndothelial dysfunctionMetabolic syndromebusinessAmerican Journal of Hypertension
researchProduct

Deleterious effect of glycation on the ability of HDL to counteract the inhibitory effect of oxidized LDL on endothelium-dependent vasorelaxation

2013

Background Contrary to high-density lipoprotein (HDL) from normolipidaemic and normoglycaemic subjects, HDL from diabetic patients loses its ability to reverse the inhibition of vasorelaxation induced by oxidized low-density lipoprotein (LDL). The aim of this study was to analyze the role of glycation, a major abnormality observed in diabetes, on the impairment of the vasorelaxant effect of HDL. Methods HDL from healthy subjects was glycated in vitro by incubation in glucose 200 mmol/L for 3 days. Vasoreactivity was evaluated by the relaxation response to acetylcholine of rabbit aorta rings pre-contracted with noradrenaline, before and after 2 h incubation with or without different lipoprot…

medicine.medical_specialtyEndotheliumbusiness.industryEndocrinology Diabetes and MetabolismVasodilationmedicine.diseasechemistry.chemical_compoundEndocrinologymedicine.anatomical_structureEndocrinologyFructosaminechemistryGlycationInternal medicineDiabetes mellitusInternal Medicinemedicinelipids (amino acids peptides and proteins)businessIncubationAcetylcholinemedicine.drugLipoproteinDiabetes/Metabolism Research and Reviews
researchProduct

Dissociation of airway responsiveness and bronchoalveolar lavage (BAL) cell composition in sensitized guinea-pigs after daily inhalation of ovalbumin

1994

Summary. The association between inflammatory cell influx, cell activation status and change of airway responsiveness to acelylcholine (ACh) after daily inhalation of ovalbumin (OA) in sensitized guinea–pigs was investigated. Starting 3 weeks after sensitization (OA at 50mg/kg s.c. + i.p.) guinea–pigs were exposed daily to 2% OA (10min: undercover of 0.5Smg/kg mepyramine i.p. 15min before OA) for 2 weeks. Concentration–response curves (CRCs) for inhaled ACh were performed 24 h after the last OA–challenge and 24 h after another single OA–inhalation 1 week later. CRCs for inhaled ACh were neither affected 24 h after the last OA challenge (daily for two weeks) nor 24 h after another OA–inhalat…

medicine.medical_specialtyEosinophil PeroxidaseOvalbuminGuinea PigsImmunologyMepyramineBronchiLeukocyte CountInternal medicineAdministration InhalationmedicineAnimalsImmunology and AllergyRespiratory systemSensitizationPeroxidasemedicine.diagnostic_testbiologyInhalationbusiness.industryAcetylcholineOvalbuminmedicine.anatomical_structureBronchoalveolar lavageEndocrinologyPeroxidasesMethylprednisoloneImmunologybiology.proteinFemaleImmunizationBronchial HyperreactivitybusinessCell activationBronchoalveolar Lavage Fluidmedicine.drugClinical <html_ent glyph="@amp;" ascii="&"/> Experimental Allergy
researchProduct

Eosinophils, pruritus and psoriasis: effects of treatment with etretinate or cyclosporin-A

1998

Abstract Background The antipsoriatic drugs cyclosporin A (CyA) and etretinate have been found to influence proinflammatory eosinophilic leukocytes and pruritus. Aim We compared the number of blood eosinophils, concentration of serum eosinophil cationic protein (ECP), and pruritus in patients with psoriasis treated with either CyA or etretinate. Study design Patients with psoriasis vulgaris were randomly assigned to treatment for 10 weeks with either CyA ( n =21) or etretinate ( n =10). The psoriasis area-and-severity index (PASI-score) and pruritus (according to a 0–3 scale) served as clinical parameters, the blood esosinophil counts (Coulter Counter) and the serum ECP (RIA, Pharmacia) as …

medicine.medical_specialtyEosinophil cationic proteinbusiness.industryKeratolyticEtretinateDermatologymedicine.diseaseGastroenterologyBlood proteinsProinflammatory cytokineInfectious DiseasesPsoriasisInternal medicineCyclosporin aEosinophilicImmunologymedicinebusinessmedicine.drugJournal of the European Academy of Dermatology and Venereology
researchProduct

Increased risk for cervical disease progression of French women infected with the human papillomavirus type 16 E6-350G variant.

2006

Abstract To test the significance of human papillomavirus (HPV) type 16 and HPV16 E6 variants as risk factors for viral persistence and progression to high-grade lesion, we did a nested case-control study within a cohort study of >15,000 Caucasian French women. Three groups infected with high-risk HPV were compared: (a) women with cleared infection (controls, n = 201), (b) women with persistent infection (cases, n = 87), and (c) women who progressed into high-grade lesion (cases, n = 58). Women with persistent HPV infection and those that progressed into high-grade lesions were likelier to harbor HPV16 than other high-risk HPV types [odds ratio (OR), 2.4; 95% confidence interval (95%…

medicine.medical_specialtyEpidemiologyUterine Cervical NeoplasmsCervical intraepithelial neoplasiaLesionCohort StudiesRisk FactorsInternal medicineEpidemiologymedicineOdds RatioHumansRisk factorbusiness.industryPapillomavirus InfectionsHPV infectionvirus diseasesOdds ratioOncogene Proteins Viralmedicine.diseaseUterine Cervical DysplasiaRepressor ProteinsOncologyCase-Control StudiesImmunologyDisease ProgressionFemaleViral diseaseFrancemedicine.symptombusinessCohort studyCancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
researchProduct